Holen Sie sich die Stockscreener-App
7.17
0.99%
0.07
Handel nachbörslich:
7.00
-0.17
-2.37%
Schlusskurs vom Vortag:
$7.10
Offen:
$7.03
24-Stunden-Volumen:
805.10K
Relative Volume:
0.43
Marktkapitalisierung:
$605.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-5.5581
EPS:
-1.29
Netto-Cashflow:
$-79.09M
1W Leistung:
+4.22%
1M Leistung:
-13.30%
6M Leistung:
+31.80%
1J Leistung:
+47.53%
1-Tages-Spanne:
$6.94
$7.215
1-Wochen-Bereich:
$6.49
$7.345
52-Wochen-Spanne:
$3.26
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
Terns Surges 29.6% in Three Months: Will the Momentum Continue? - MSN
Critical Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $15.90 - Defense World
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Oppenheimer initiates Terns Pharmaceuticals stock at Outperform, sees 150% upside - Investing.com Australia
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $15.90 Average Target Price from Analysts - MarketBeat
Terns Pharmaceuticals (NASDAQ:TERN) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
Objective long/short (TERN) Report - Stock Traders Daily
Bleakley Financial Group LLC Purchases 2,751 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
SG Americas Securities LLC Buys Shares of 23,810 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Financial Comparison: Oculis (NASDAQ:OCS) and Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Will The LIFT Data Boost Terns Stock? - RTTNews
Terns Pharmaceuticals: Another Potential GLP-1 Entrant (NASDAQ:TERN) - Seeking Alpha
Top investors say Terns Pharmaceuticals Inc (TERN) ticks everything they need - SETE News
(TERN) Technical Pivots with Risk Controls - Stock Traders Daily
A stock that deserves closer examination: Terns Pharmaceuticals Inc (TERN) - US Post News
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Short Interest Update - MarketBeat
Mizuho gives a Buy recommendation for Terns Pharmaceuticals Inc (TERN) - Knox Daily
Why Terns Pharmaceuticals Inc Stock Might Make Sense If Bought Today - Stocks Register
Marshall Wace LLP Decreases Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Sold by Marshall Wace LLP - MarketBeat
Institutional investors in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) lost 9.7% last week but have reaped the benefits of longer-term growth - Simply Wall St
Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 6.2%Here's Why - MarketBeat
Terns Pharmaceuticals Inc (TERN) looking to reclaim success with recent performance - SETE News
Buying Buzz: Terns Pharmaceuticals Inc [TERN] Director Lu Hongbo purchases 476,190 shares of the company - Knox Daily
Renaissance Technologies LLC Takes Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Terns Pharmaceuticals Inc: Rising -32.47% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Gaining Ground: Terns Pharmaceuticals Inc (TERN) Closes Higher at 8.27, Up 0.85 - The Dwinnex
Understanding the Risks of Investing in Terns Pharmaceuticals Inc (TERN) - Knox Daily
How to interpret Terns Pharmaceuticals Inc (TERN)’s stock chart patterns - US Post News
Terns Pharmaceuticals (TERN) Stock Price, News & Analysis - MarketBeat
Trend Tracker for (TERN) - Stock Traders Daily
Ready to Jump After Recent Trade: Terns Pharmaceuticals Inc (TERN) - SETE News
Examining Terns Pharmaceuticals Inc (TERN) stock is warranted - US Post News
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by Point72 Asset Management L.P. - Defense World
Analysts review Terns Pharmaceuticals Inc’s rating - Knox Daily
Terns Pharmaceuticals stock target lifted on obesity drug data By Investing.com - Investing.com Canada
Terns Pharmaceuticals' SWOT analysis: obesity drug shows promise, stock potential rises - Investing.com
Trading Day Triumph: Terns Pharmaceuticals Inc (TERN) Ends at 8.55, a -3.39 Surge/Plunge - The Dwinnex
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Purchased by Point72 Asset Management L.P. - MarketBeat
Short Interest in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Increases By 41.4% - MarketBeat
Rhumbline Advisers Increases Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst - Seeking Alpha
(TERN) Investment Analysis - Stock Traders Daily
Great Point Partners LLC Sells 160,569 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Insiders Snap Up These 2 ‘Strong Buy’ Stocks - Markets Insider
Terex (NYSE:TEX) PT Lowered to $57.00 - Defense World
Interval Partners LP Makes New $10.41 Million Investment in TransDigm Group Incorporated (NYSE:TDG) - Defense World
Terns Pharmaceuticals Inc (TERN) requires closer examination - US Post News
Financial Metrics Check: Traws Pharma Inc. (TRAW)’s Ratios for Trailing Twelve Months - The Dwinnex
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):